EMA recommends restricting cilostazol use for PAD

The Europeans Medicines Agency has recommended restricting the use of cilostazol in patients with intermittent claudication. Use should be avoided in those with cardiac problems or on dual anticoagulants.
Source: theHeart.org - Category: Cardiology Source Type: news